Successful use of fidaxomicin in recurrent clostridium difficile infection in a child

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 7, 2013, Pages 1688-1689

  Smeltzer, Stephanie ^a   Hassoun, Ali ^b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b Alabama Infectious Diseases Center   (United States)

Author keywords

Diarrhoea; Macrocyclic antibiotics; Paediatric infections; Pseudomembranous colitis

Indexed keywords

CLARITHROMYCIN; FIDAXOMICIN; METRONIDAZOLE; VANCOMYCIN;

CHILDHOOD MORTALITY; CHROMOSOME DISORDER; CLOSTRIDIUM DIFFICILE INFECTION; DIARRHEA; DRUG DOSE REDUCTION; ENTERIC FEEDING; FOLLOW UP; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; LETHARGY; LETTER; MICROCEPHALY; NEUTROPHIL COUNT; PHYSICAL EXAMINATION; PNEUMONIA; RECURRENT INFECTION; ROTAVIRUS INFECTION; SEIZURE; STOMACH DISTENSION; TREATMENT DURATION;

EID: 84879479722     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt079     Document Type: Letter

References (8)

1. Zilberberg MD, Tillotson GS, McDonald LC. Clostridium difficile infections among hospitalized children, United States, 1997-2006. Emerg Infect Dis 2010; 16: 604-9.
2. Kim J, Smathers S, Prasad P et al. Epidemiological features of Clostridium difficile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Paediatrics 2008; 122: 1266-70.
3. Kim J, Shaklee JF, Smathers S, et al. Risk factors and outcomes with severe Clostridium difficile infection in children. Pediatr Infect Dis J 2012; 31: 134-8.
4. Vardakas KZ, Polyzos KA, Patouni K, et al. Treatment failure and recurrence of Clostridium difficile infections following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents 2012; 40: 1-8.
5. Fidaxomicin (Package Insert). San Diego, CA: Optimer Pharmaceuticals, 2011.
6. Johnson AP, Wilcox MH. Fidaxomicin: a new option for the treatment of Clostridium difficile infection. J Antimicrob Chemother 2012; 67: 2788-92.
7. Louie TJ, Miller MA, Mullane KM, et al. Fidaxomicin versus vancomycin for Clostridium difficle infection. N Engl J Med 2011; 364: 422-31.
8. American Society of Health-System Pharmacists. CMS to Compensate Hospitals for Inpatient Use of Fidaxomicin, Glucarpidase. http://www. ashp.org/menu/News/PharmacyNews/NewsArticle.aspx?id=3787 (20 October 2012, date last accessed).